Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials

Molecules. 2022 Jun 25;27(13):4090. doi: 10.3390/molecules27134090.

Abstract

Of the biologically active components, polysaccharides play a crucial role of high medical and pharmaceutical significance. Mushrooms have existed for a long time, dating back to the time of the Ancient Egypt and continue to be well explored globally and experimented with in research as well as in national and international cuisines. Mushroom polysaccharides have slowly become valuable sources of nutraceuticals which have been able to treat various diseases and disorders in humans. The application of mushroom polysaccharides for anticancer mycotherapy is what is being reviewed herein. The widespread health benefits of mushroom polysaccharides have been highlighted and the significant inputs of mushroom-based polysaccharides in anticancer clinical trials have been presented. The challenges and limitation of mushroom polysaccharides into this application and the gaps in the current application areas that could be the future direction have been discussed.

Keywords: anticancer; clinical trials; glucans; lentinans; mushroom polysaccharides; treatment.

Publication types

  • Review

MeSH terms

  • Agaricales / chemistry*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Dietary Supplements
  • Humans
  • Neoplasms / drug therapy*
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Polysaccharides

Grants and funding

This research received no external funding.